当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A Vision for Democratizing Next-Generation Oncology Clinical Trials
Cancer Discovery ( IF 29.7 ) Pub Date : 2024-04-04 , DOI: 10.1158/2159-8290.cd-24-0017 Vivek Subbiah 1 , Denis Horgan 2 , Ishwaria M Subbiah 1, 3
Cancer Discovery ( IF 29.7 ) Pub Date : 2024-04-04 , DOI: 10.1158/2159-8290.cd-24-0017 Vivek Subbiah 1 , Denis Horgan 2 , Ishwaria M Subbiah 1, 3
Affiliation
Summary: Revolutionary advancements in oncology have transformed lives, but the clinical trials ecosystem encounters challenges, including restricted access to innovative therapies and a lack of diversity in participant representation. A vision emerges for democratized, globally accessible oncology trials, necessitating collaboration among researchers, clinicians, patients, and policymakers to shift from converting complex, exclusive trials into a dynamic, inclusive force against cancer.
中文翻译:
下一代肿瘤学临床试验民主化的愿景
摘要:肿瘤学的革命性进步改变了人们的生活,但临床试验生态系统遇到了挑战,包括获得创新疗法的机会有限以及参与者代表性缺乏多样性。民主化、全球可及的肿瘤学试验的愿景出现,需要研究人员、临床医生、患者和政策制定者之间的合作,从复杂的、排他性的试验转变为动态的、包容性的抗癌力量。
更新日期:2024-04-04
中文翻译:
下一代肿瘤学临床试验民主化的愿景
摘要:肿瘤学的革命性进步改变了人们的生活,但临床试验生态系统遇到了挑战,包括获得创新疗法的机会有限以及参与者代表性缺乏多样性。民主化、全球可及的肿瘤学试验的愿景出现,需要研究人员、临床医生、患者和政策制定者之间的合作,从复杂的、排他性的试验转变为动态的、包容性的抗癌力量。